SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-4 - Registration of securities, foreign private issuers, business combinations:
SEC Accession No. 0001395064-19-000024
Filing Date
2019-08-09
Accepted
2019-08-09 06:27:58
Documents
12

Document Format Files

Seq Description Document Type Size
1 FORM F-4 formf4_080919.htm F-4 9446507
2 EXHIBIT 4.5 exhibit45.htm EX-4.5 73779
3 EXHIBIT 4.14 exhibit414.htm EX-4.14 37154
4 EXHIBIT 5.1 exhibit51.htm EX-5.1 8031
5 EXHIBIT 5.2 exhibit52.htm EX-5.2 21881
6 EXHIBIT 23.1 exhibit231.htm EX-23.1 2836
7 EXHIBIT 23.2 exhibit232.htm EX-23.2 2171
8 EXHIBIT 25.1 exhibit251.htm EX-25.1 41378
9 image1.gif GRAPHIC 4734
10 mufgexhibit82.jpg GRAPHIC 620470
11 mufgexhibit83.jpg GRAPHIC 620578
12 mufgexhibit85.jpg GRAPHIC 401710
  Complete submission text file 0001395064-19-000024.txt   11903943
Mailing Address 1-1, DOSCHOMACHI 4-CHOME CHUO-KU, OSALCA 540-8645 M0 00000
Business Address 1-1, DOSCHOMACHI 4-CHOME CHUO-KU, OSALCA 540-8645 M0 00000
TAKEDA PHARMACEUTICAL CO LTD (Filer) CIK: 0001395064 (see all company filings)

IRS No.: 000000000
Type: F-4 | Act: 33 | File No.: 333-233160 | Film No.: 191011251
SIC: 2834 Pharmaceutical Preparations